Literature DB >> 26139368

RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Viachaslau Bernat1, Matthew D Disney2.   

Abstract

RNAs adopt diverse folded structures that are essential for function and thus play critical roles in cellular biology. A striking example of this is the ribosome, a complex, three-dimensionally folded macromolecular machine that orchestrates protein synthesis. Advances in RNA biochemistry, structural and molecular biology, and bioinformatics have revealed other non-coding RNAs whose functions are dictated by their structure. It is not surprising that aberrantly folded RNA structures contribute to disease. In this Review, we provide a brief introduction into RNA structural biology and then describe how RNA structures function in cells and cause or contribute to neurological disease. Finally, we highlight successful applications of rational design principles to provide chemical probes and lead compounds targeting structured RNAs. Based on several examples of well-characterized RNA-driven neurological disorders, we demonstrate how designed small molecules can facilitate the study of RNA dysfunction, elucidating previously unknown roles for RNA in disease, and provide lead therapeutics.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26139368      PMCID: PMC4508199          DOI: 10.1016/j.neuron.2015.06.012

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  301 in total

1.  Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.

Authors:  Clotilde Lagier-Tourenne; Michael Baughn; Frank Rigo; Shuying Sun; Patrick Liu; Hai-Ri Li; Jie Jiang; Andrew T Watt; Seung Chun; Melanie Katz; Jinsong Qiu; Ying Sun; Shuo-Chien Ling; Qiang Zhu; Magdalini Polymenidou; Kevin Drenner; Jonathan W Artates; Melissa McAlonis-Downes; Sebastian Markmiller; Kasey R Hutt; Donald P Pizzo; Janet Cady; Matthew B Harms; Robert H Baloh; Scott R Vandenberg; Gene W Yeo; Xiang-Dong Fu; C Frank Bennett; Don W Cleveland; John Ravits
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

Review 2.  Splicing regulation in neurologic disease.

Authors:  Donny D Licatalosi; Robert B Darnell
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

3.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.

Authors:  Dobrila D Rudnicki; Susan E Holmes; Mark W Lin; Charles A Thornton; Christopher A Ross; Russell L Margolis
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

5.  Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Jihae Shin; Yuan Yuan; Stuart G Beattie; Thurman M Wheeler; Charles A Thornton; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

6.  Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.

Authors:  Zihui Xu; Mickael Poidevin; Xuekun Li; Yujing Li; Liqi Shu; David L Nelson; He Li; Chadwick M Hales; Marla Gearing; Thomas S Wingo; Peng Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

Review 7.  Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.

Authors:  David Olivares; Xudong Huang; Lars Branden; Nigel H Greig; Jack T Rogers
Journal:  Int J Mol Sci       Date:  2009-03-17       Impact factor: 5.923

8.  RNAalifold: improved consensus structure prediction for RNA alignments.

Authors:  Stephan H Bernhart; Ivo L Hofacker; Sebastian Will; Andreas R Gruber; Peter F Stadler
Journal:  BMC Bioinformatics       Date:  2008-11-11       Impact factor: 3.169

9.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

Review 10.  Functional long-range RNA-RNA interactions in positive-strand RNA viruses.

Authors:  Beth L Nicholson; K Andrew White
Journal:  Nat Rev Microbiol       Date:  2014-07       Impact factor: 60.633

View more
  47 in total

Review 1.  Small molecule targeting of RNA structures in neurological disorders.

Authors:  Alicia J Angelbello; Jonathan L Chen; Matthew D Disney
Journal:  Ann N Y Acad Sci       Date:  2019-04-09       Impact factor: 5.691

2.  Identifying and validating small molecules interacting with RNA (SMIRNAs).

Authors:  Matthew D Disney; Sai Pradeep Velagapudi; Yue Li; Matthew G Costales; Jessica L Childs-Disney
Journal:  Methods Enzymol       Date:  2019-05-15       Impact factor: 1.600

3.  SMMDB: a web-accessible database for small molecule modulators and their targets involved in neurological diseases.

Authors:  Subodh Kumar Mishra; Neha Jain; Uma Shankar; Arpita Tawani; Amit Mishra; Amit Kumar
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

4.  A Toxic RNA Catalyzes the Cellular Synthesis of Its Own Inhibitor, Shunting It to Endogenous Decay Pathways.

Authors:  Raphael I Benhamou; Alicia J Angelbello; Eric T Wang; Matthew D Disney
Journal:  Cell Chem Biol       Date:  2020-01-24       Impact factor: 8.116

Review 5.  Repeat-associated RNA structure and aberrant splicing.

Authors:  Melissa A Hale; Nicholas E Johnson; J Andrew Berglund
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-16       Impact factor: 4.490

6.  RNA: Opening New Doors in Medicinal Chemistry.

Authors:  Amanda L Garner; Stevan W Djuric
Journal:  ACS Med Chem Lett       Date:  2020-08-19       Impact factor: 4.345

7.  Discovery of Key Physicochemical, Structural, and Spatial Properties of RNA-Targeted Bioactive Ligands.

Authors:  Brittany S Morgan; Jordan E Forte; Rebecca N Culver; Yuqi Zhang; Amanda E Hargrove
Journal:  Angew Chem Int Ed Engl       Date:  2017-09-18       Impact factor: 15.336

8.  Site-specific covalent labeling of large RNAs with nanoparticles empowered by expanded genetic alphabet transcription.

Authors:  Yan Wang; Yaoyi Chen; Yanping Hu; Xianyang Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

9.  Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNA.

Authors:  Jessica E Wynn; Wenyu Zhang; Denis M Tebit; Laurie R Gray; Marie-Louise Hammarskjold; David Rekosh; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2016-04-05       Impact factor: 3.641

Review 10.  Chemical Tools for Dissecting the Role of lncRNAs in Epigenetic Regulation.

Authors:  Sarah Nainar; Chao Feng; Robert C Spitale
Journal:  ACS Chem Biol       Date:  2016-06-27       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.